International Stem Cell (ISCO) Receivables (2016 - 2025)
Historic Receivables for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $1.0 million.
- International Stem Cell's Receivables rose 4926.47% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 4926.47%. This contributed to the annual value of $1.1 million for FY2024, which is 8432.06% up from last year.
- According to the latest figures from Q3 2025, International Stem Cell's Receivables is $1.0 million, which was up 4926.47% from $1.1 million recorded in Q2 2025.
- In the past 5 years, International Stem Cell's Receivables registered a high of $1.1 million during Q2 2025, and its lowest value of $427000.0 during Q3 2022.
- In the last 5 years, International Stem Cell's Receivables had a median value of $680000.0 in 2024 and averaged $734210.5.
- The largest annual percentage gain for International Stem Cell's Receivables in the last 5 years was 10942.93% (2021), contrasted with its biggest fall of 6159.93% (2021).
- International Stem Cell's Receivables (Quarter) stood at $844000.0 in 2021, then decreased by 11.49% to $747000.0 in 2022, then dropped by 23.16% to $574000.0 in 2023, then soared by 84.32% to $1.1 million in 2024, then dropped by 4.06% to $1.0 million in 2025.
- Its Receivables stands at $1.0 million for Q3 2025, versus $1.1 million for Q2 2025 and $851000.0 for Q1 2025.